MagForce

View in Terminal

Loading quotes...

Forecast

There is no analyst data available for this company.

News Go to news feed

There is currently no news available for this company. We are working on adding more providers to change this.

Financials

In the last year, MagForce had revenue of €351.98K and net profit of -€10.57M

(EUR)	2021	YoY
Revenue	351.98K	43.33%
Gross profit	-316.61K	172.84%
Net profit	-10.57M	171.71%
EBITDA	-5.63M	130.50%

Fundamentals

Metric	Value
Market capitalization	€3.49M
Number of shares	29.93M
52-week high/low	€3.94 - €0.11
Dividends	No
Beta	3.02
P/E ratio	-291.25
PEG ratio	-2.91
P/B ratio	129.91
P/S ratio	9.91

Company profile

MagForce AG operates in the field of nanotechnology-based cancer therapy in Germany and Poland. It offers NanoTherm, a therapy for the treatment of solid tumors; NanoPlan, a simulation software that helps the treating physicians to define the NanoTherm therapy schedule according to the distribution of the NanoTherm depots in the tumor; and NanoActivator, a magnetic field applicator. MagForce AG was founded in 1997 and is headquartered in Berlin, Germany.